Recommended Free Tools
Neither treatment has been proven superior. The best current comparison is indirect: a 2024 network meta-analysis found antidepressant effects for both psilocybin and intravenous (IV) racemic ketamine, with a possible early-onset advantage for IV ketamine. The analysis included no head-to-head trials, and confidence in its estimates ranged from very low to moderate.
That distinction matters. Results from IV racemic ketamine cannot be applied automatically to intranasal esketamine or every ketamine-clinic protocol, while psilocybin remains an investigational depression treatment in the United States. Choosing between them requires a qualified clinician who can assess diagnosis, medical history, medications, risks and local regulations.
As an Amazon Associate I earn from qualifying purchases.
What the evidence actually compares
The most direct overview is Terao and colleagues’ 2024 network meta-analysis of randomized trials in major depressive disorder. It brought together 28 randomized controlled trials involving IV racemic ketamine, psilocybin interventions and theta-burst stimulation. A network meta-analysis can estimate differences through a shared placebo or comparator even when two treatments have not been tested against each other, but it is not a substitute for a randomized head-to-head study. The authors reported confidence ranging from very low to moderate and noted a scarcity of psilocybin trials. Read the full analysis at the published review.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstall| Question | What the evidence shows | What it does not show |
|---|---|---|
| Are there direct psilocybin-versus-ketamine trials? | No direct comparison trials were identified in the network analysis. | It cannot establish which treatment is better for an individual. |
| Which ketamine product was studied? | Intravenous racemic ketamine. | The findings do not automatically apply to intranasal esketamine, oral or compounded products, or every clinic protocol. |
| How certain are the estimates? | Confidence ranged from very low to moderate. | A statistically significant result is not the same as high-certainty proof. |
| What condition was studied? | Major depressive disorder in randomized trials. | Results should not be generalized to every diagnosis, symptom pattern or patient group. |
A separate 2024 meta-analysis by Menon and colleagues pooled randomized trials of psilocybin-assisted therapy against each study’s comparator. It reported a one-week depression-score standardized mean difference of −0.72 (95% confidence interval −0.95 to −0.49; five trials; 403 participants), a response risk ratio of 3.42 (95% CI 2.35–4.97) and a remission risk ratio of 3.66 (95% CI 2.26–5.92; four trials; 373 participants). Those estimates describe psilocybin-assisted therapy versus the comparators used in those trials; they are not estimates against ketamine. The paper is available from Acta Psychiatrica Scandinavica.
#1 Best Overall
- [Ultra-Lightweight Ear Buds Designed for Small Ears] Each earbud weighs only 3.7g and features a compact, ergonomic in-ear design made especially for small ears. Secure, low-profile, and comfortable for workouts, all-day wear or overnight sleeping.The ultra-slim profile sits flush in your ear with no hard edges poking or rubbing, so you can even sleep on your side without discomfort.
- [Immersive Stereo Sound with TOZO OrigX Technology] TOZO OrigX tuning delivers clear vocals, balanced mids, and natural stereo sound for music, podcasts, and videos.
- [Long Battery Life for Daily Use] Get up to 7 hours of playtime on a single charge, with up to 32 hours total using the charging case—ideal for workdays, commuting, and extended listening sessions.
- [Bluetooth 5.3 & Stable Connection] Bluetooth 5.3 provides fast pairing, stable wireless performance, and reduced dropouts as you move around home or office.
- [Deep Bass with Clear Vocals] High-performance drivers produce punchy bass while keeping vocals clean and detailed for everyday listening.
Which works faster for depression?
Speed is the clearest potential difference, but it is still an indirect finding. In Terao’s subgroup covering outcomes measured one week or less, only IV racemic ketamine was significantly more effective than placebo. This pattern is consistent with ketamine producing symptom relief within hours or days for some participants. It does not prove that ketamine would outperform psilocybin in a direct trial, because the treatments were tested in different study networks with different participants, procedures and outcome measurements.
Psilocybin trials also found benefit by about one week. Menon’s pooled estimate above measures change at that time point, and the response and remission ratios favored psilocybin-assisted therapy over its trial comparators. A one-week result does not mean every participant improves that quickly, nor does it identify how much of the change came from the drug, the psychological support, expectations or the combination.
What happens after four weeks or longer?
When Terao and colleagues examined outcomes at four weeks or later, both IV racemic ketamine and psilocybin were significantly better than placebo in the network analysis. This indicates that effects can still be detected beyond the first week for both interventions under the conditions studied.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Rank #2
- 【IP68 Waterproof Multifunctinal Smart Watch】Torjalph fitness activity tracker smart watch is IP68 waterproof technology ,you can wear it when swimming,handwashing,it's rain-proof which means that you perform multiple exercise modes outside without worrying about sweat or rain corroding your fitness smart watch,and this watch equipped with a 230 mAh large capacity battery magnetic charging ,and this sports activity tracker watch can be used 5-7 days If fully charged.
- 【Larger 1.83'' Full Screen Watch & Multi-dial Selection】1.83 inch full HD color touch screen smart watch for men / women provides excellent 240*284 resolution image quality ,This Bluetooth smart watch offers a better touch experience and remarkable immersion and ,more than 200 watch faces for you to choose from App"Da Fit ", you can change the dial style according to your mood to wear keeping the world on your wrist
- 【Accurate Activity Tracker Smart Watch 】sports watch activity tracker uses sweat and dust resistant breathable silicone strap, our Fitness Tracker Smart Watch for Android iOS Phones supports 12 sports modes,walking,running,bicycle,swimming,badminton,basketball,football,rope skipping. This bluetooth calls smart watch for men women is lightweight and stylish, bringing more convenient and relaxing sports experience while also providing more protection.
- 【Your 24 Hour Personal Daily Health Monitor】Fitness watch for women men full touch screen IP67 waterproof bluetooth smartwatch for Android iOS Phones with heart rate blood pressure monitor multifunction Andriod smart watch with steps counter sleep monitor sports fitness watch, monitoring blood oxygen saturation allows you to understand your physical condition in real time to track fitness progress ,to know your health status in time.
- 【More Functions Bluetooth Call Smart Watch】This fitness activity smart watch full screen for iPhone and Android phones includes a bunch of new features including:The bluetooth smart watch can hang up the phone, receive and display WhatsAPP /Text /Facebook /Twitter /Messenger reminder.Support sedentary reminder, alarm clock, stopwatch, timer,weather information,music control, remote camera control compatible with Android 5.0 and above or iOS 9.0 and above smartphones.
The follow-up windows do not answer how long benefits last after treatment stops. The reviewed evidence does not establish a universally effective maintenance schedule, the number of booster sessions, the best interval between treatments or which therapy should be tried first. A four-week or later measurement is a study time point, not a guarantee of durable remission. A 2024 systematic review that compared psilocybin with esketamine using indirect number-needed-to-treat estimates likewise called for replication and longer-term maintenance studies; its conclusions are hypothesis-generating rather than head-to-head proof. See the systematic review.
How the treatment experience differs
IV racemic ketamine
In the comparative trials, ketamine was delivered intravenously as a racemic mixture under clinical supervision. An infusion model allows a team to observe a patient during dosing and recovery, but it also requires an equipped facility, trained staff and time for monitoring. The network result should not be used to represent intranasal esketamine, which is a different formulation with its own regulatory and service requirements, or unregulated home-use and compounded products.
Psilocybin-assisted therapy
Psilocybin studies generally pair a supervised dosing session with psychological preparation and support, followed by integration or follow-up visits. The therapeutic model is therefore more than taking a capsule: setting, supervision, session length and therapist involvement can all influence the experience and the measured outcome. Protocols differ across trials, so a result from one research program may not describe a commercial or community service.
Rank #3
- [Low Noise High Fidelity] New bee guitar cord with 22AWG oxygen-free-copper center conductors provides enhanced signal transfer, the PVC insulation material and the high-density stranded copper double shield provide noise rejection for quiet operation
- [Ideal for Choice] New bee 1/4 straight and right angle metal connectors, ensures a secure connection in any instrument, pedal, or amp jack. L shape great fro on stage guitar stands
- [Wide Compatible] Suitable for mixer, power amplifier, microphone, effector, decoder, equalizer, electoronic organ, electric guitar, electric bass and other electronic equipments. Widely used in the installation of smart home, karaoke speaker, professional stage audio, etc
- [Easy Disassemble] Making incidental repairs quick and easy! Very nice, flexible cable
- [Dont Hesite to Order] 24 hours customer services and professional technology team are standing by
Why format prevents simple rankings
“Ketamine therapy” can refer to IV racemic ketamine, intranasal esketamine or other services that differ in dose, monitoring and follow-up. “Psilocybin therapy” can also mean a tightly controlled research protocol rather than a legally available clinic. Comparing names without comparing formulation, route, supervision and follow-up can create a false impression that all versions are interchangeable.
What is known about side effects and safety?
Safety comparisons are limited because the studies were not designed as a direct adverse-event contest and used different controls and monitoring. In the network meta-analysis, neither tolerability nor acceptability differed significantly from placebo, but the authors rated confidence as limited. “No significant difference” should not be read as proof that risks are equal or absent.
Menon’s psilocybin-assisted-therapy meta-analysis found a higher risk of reporting any adverse event than comparators (risk ratio 1.20, 95% CI 1.01–1.42). Headache risk was also higher (RR 1.78, 95% CI 1.10–2.86), as was dizziness (RR 6.52, 95% CI 1.19–35.87). The dizziness interval is very wide, so the exact size of that excess is uncertain. These figures come from the included trials and do not provide an absolute risk for a particular patient, nor do they compare psilocybin directly with ketamine.
Rank #4
- Digital Family Calendar: BSIMB digital calendar wall touch screen puts an end to your chaotic life. Designed for busy families, the digital calendar keeps you organised and in step with your family. Assign different colours and tasks to each family member to make family scheduling easier and more intuitive.
- Easy Setup and Auto-Sync: Plug in, connect to WLAN and auto-syn your electric calendar in minutes. Digital wall calendar compatible with Google calendar, iCloud calendar, Outlook calendar, Cozi calendar and Yahoo calendar. Add events directly on the device or through the ecalendar app. Electronic calendar stays current whether you're at work or traveling—no manual updates needed.
- All-In-One Home Assistant: Smart calendar builds habits and encourage independence with personalised chores. Display daily meal plan to reduce the daily ‘What's for dinner?’ stress. To-do lists keep track of everything you want. Turning chores into valuable achievements with stars and rewards, making life easier and more enjoyable.
- Manage Anytime Anywhere: BSIMB electronic calendar for family stay connected with the powerful ecalendar app. Access and manage your digital wall calendar anytime, anywhere with free features like stars & rewards, photo screensaver, chore charts, meals plans, to-do lists etc. Electronic planner paid features like Magic Import tailor advanced tools for users with special needs.
- Stay in Touch with Loved Ones: Share photos or videos from your phone to electronic wall calendar with app, instantly update your life moment, and keep in touch with your family, especially those who are far away; you can also surprise your smart calendar digital wall by sending him a wish card; it's also great for keeping tech-illiterate elders in touch with the youngsters.
Both treatments can involve intense short-term psychological and physical effects, which is why research protocols use screening, preparation, supervision and post-session observation. The reviewed sources do not provide a complete current comparison of contraindications, medication interactions, eligibility rules or individualized risk. Someone considering either treatment should discuss those issues with a licensed clinician rather than rely on a trial average.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Regulatory status and practical availability
In the United States, the regulatory status of psilocybin and ketamine must be separated from the results of clinical trials. The U.S. Food and Drug Administration’s July 2026 document is final guidance for sponsors conducting clinical investigations of psychedelic drugs. It says: “This final guidance provides general considerations for sponsors developing psychedelic drugs for the treatment of medical conditions (e.g., psychiatric disorders, substance use disorders) and discusses recommendations for clinical investigations using psychedelic drugs.” The guidance page is at FDA.gov. That document does not itself establish an approved psilocybin depression therapy.
Ketamine’s legal route, formulation and indication vary by jurisdiction. IV racemic ketamine used in research is not the same regulatory product as intranasal esketamine, and a clinic’s advertising does not determine whether its protocol is supported by the randomized evidence summarized here. Availability, insurance coverage, supervision standards and eligibility rules must be verified locally and at the time of care. Do not infer legality or approval in one country from the rules of another.
How to interpret claims that one is “better”
When you see a clinic or article declare a winner, check the comparison behind the headline:
- Was it a direct randomized trial? If not, an apparent advantage may reflect differences between study populations, controls or follow-up times.
- Which formulation and route were tested? IV racemic ketamine, intranasal esketamine and other ketamine services should be labeled separately.
- What outcome and time point were used? Early symptom change, response, remission and sustained recovery are different outcomes.
- How certain is the estimate? Confidence from very low to moderate leaves substantial room for the true effect to differ.
- What support surrounded the dose? Preparation, monitoring and integration are part of the studied intervention, especially for psilocybin-assisted therapy.
- Were harms reported completely? Relative risks without absolute event rates or with wide confidence intervals cannot predict an individual’s experience.
Questions to take to a qualified clinician
A clinician can put the evidence into the context the trials cannot provide for you. Useful questions include:
- Which exact product and route are you proposing, and is it approved for my diagnosis where I live?
- What screening, monitoring and emergency procedures are in place during and after dosing?
- How will my current medicines, alcohol or other substances affect eligibility or risk?
- What follow-up is planned if symptoms return, and what alternatives are available?
- What evidence supports this specific protocol rather than a different formulation or research setting?
What remains unanswered
Researchers still need well-designed, adequately powered head-to-head trials that compare matched patient groups, clearly defined ketamine and psilocybin protocols, and the same depression outcomes at the same time points. Longer follow-up is needed to determine durability and maintenance treatment. Studies should also clarify which patients benefit, who is more likely to experience harm, and how psychotherapy, expectation and clinical setting contribute to outcomes.
For now, the defensible conclusion is narrow: both psilocybin and IV racemic ketamine show antidepressant effects in their respective trial networks; IV ketamine may act faster in the first week; and neither has been established as universally better. Those findings describe populations and protocols, not a personal treatment recommendation.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
